Biosortia Pharmaceuticals moves its corporate headquarters to biopharma hub in San Diego, California San Diego, California (January 11, 2016) – Biosortia Pharmaceuticals Inc. announces today that it has been selected by Johnson & Johnson Innovation – JLABS (JLABS) to operate as a resident company within its flagship JLABS facility in San Diego. Biosortia, a leader in
Dublin, OH (January 11, 2016) – Biosortia Pharmaceuticals, a leader in discovering and co-developing potent novel bioactive compounds with a primary focus on drug discovery for cancer, infectious disease, and anti-inflammatory therapeutics, has announced today that interim CEO, Ross O. Youngs will be presenting at Life Science Nation’s RESI San Francisco. Life Science Nation’s distinguished investor
